S4 Ep12: Inspiring Better Dialogues in UC Care – The CONFIDE Study

There are currently about 7 million people globally living with inflammatory bowel disease (IBD), a chronic disease that encompasses both ulcerative colitis and Crohn’s disease. The disease can affect how people work, travel and spend time with family and friends, and can make it difficult to talk about with loved ones and healthcare providers.

The CONFIDE survey is a global cross-sectional survey of more than 800 healthcare professionals and more than 1,600 adults living with ulcerative colitis and Crohn's disease in the United States, Europe and Japan. The study was designed to better understand the burden, barriers and care experiences of those living with moderate to severely active ulcerative colitis and Crohn's disease and how they communicate with their healthcare providers.

Guest host Dr. Cem Kayhan, U.S. and Global Head, Medical Affairs, Gastroenterology at Lilly, is joined by Dr. David Rubin, Section Chief of Gastroenterology at University of Chicago, Lilly’s Dr. Deborah Fisher, U.S. Medical Affairs, Gastroenterology, and Eoin Flynn, Global Scientific Communications Manager at Lilly, who also serves as a patient advisor for the CONFIDE studies, as he lives with ulcerative colitis. The group will discuss how Lilly’s CONFIDE survey sheds light on key gaps in patient-doctor communication that can impact optimal treatment approaches and reinforce the stigma that can be associated with these diseases.